Aidoc

Company Overview

Snapshot

Founded in February 2016 by Elad Walach, Gal Yaniv, Michael Braginsky, and Guy Reiner, Aidoc is a Health Tech & Life Sciences company with over 500 employees. The company has raised over $524 million across 10 funding rounds from 15 investors. In April 2026, Aidoc secured an E Round of funding, with Goldman Sachs Private Capital Investing as a lead investor.

Business overview

Aidoc is a clinical AI company focused on optimizing patient treatment and improving clinical outcomes through its proprietary aiOS platform. The company analyzes and aggregates medical data to enable care teams to manage unexpected situations and maintain a patient-centric focus. Aidoc's AI solutions operate continuously in the background, serving the healthcare industry by providing advanced medical decision support, particularly in diagnostics and radiology, utilizing artificial intelligence, machine learning, and computer vision technologies.

Strategic signal

In April 2026, Aidoc completed a $150 million funding round, bringing its total capital raised to approximately half a billion dollars. This significant investment signals strong investor confidence in Aidoc's leadership in clinical AI and its potential to further advance AI in clinical decision-making, reinforcing its strategic position in the health tech market.

Company Intelligence Q&A

What was Aidoc's most recent funding activity?

In April 2026, Aidoc secured an E Round of funding. Goldman Sachs Private Capital Investing was a lead investor in this round, which contributed to the company's total raised capital of over $524 million.

What significant FDA clearance did Aidoc receive in January 2026?

In January 2026, Aidoc secured FDA clearance for its comprehensive AI triage solution, CARE™, which integrates 11 newly cleared indications with three existing ones. This marks the first approval of a double-digit set of acute indications powered by a single AI foundation model, enhancing patient flow and reducing delays in Emergency Departments.

What strategic leadership appointment did Aidoc make in January 2026?

In January 2026, Aidoc appointed Dr. Jesse M. Ehrenfeld, former President of the American Medical Association, as its Chief Medical Officer. This appointment aims to enhance Aidoc's clinical AI strategy and support health systems in adopting comprehensive AI solutions.

Which major health system expanded its partnership with Aidoc in December 2025?

In December 2025, WellSpan Health expanded its strategic partnership with Aidoc to scale Aidoc's AI Operating System (aiOS) across its nine hospitals and over 250 care locations. This collaboration aims to enhance diagnostic accuracy and efficiency in radiology for over a million patients annually.

What new AI framework did Aidoc release in June 2025?

In June 2025, Aidoc released BRIDGE, an open-source framework developed in collaboration with NVIDIA and other organizations. BRIDGE is designed to guide healthcare organizations in safely and effectively deploying AI into clinical workflows, addressing technical, regulatory, and operational criteria for AI integration.